What Has Been the Growth Trajectory for the Constipation Treatment Market in Recent Years?
The constipation treatment market has seen considerable growth due to a variety of factors.
•The market size of constipation treatment has seen a robust growth in the recent past. The market which stood at $11.72 billion in 2024 is projected to reach $12.39 billion by 2025, growing at a compound annual growth rate (CAGR) of 5.7%.
The historical growth can be attributed to factors like increasing occurrences of digestive disorders, demographic shifts, lifestyle changes, constrained treatment choices, and growing health awareness.
How Does the Forecast Look for the Constipation Treatment Market?
The constipation treatment market is expected to maintain its strong growth trajectory in upcoming years.
• The market for constipation remedies is projected to experience significant growth in the coming years, escalating to $16.62 billion by 2029 with a compound annual growth rate (CAGR) of 7.6%.
Factors contributing to the growth during the forecast period include heightened healthcare spending, augmented emphasis on preventive healthcare, attention towards pediatric constipation, surging demand for individualized healthcare solutions, telemedicine advancements, e-commerce expansion, and a focus on functional foods and probiotics. Dominant trends during the forecast period feature technological progression in healthcare, the incorporation of artificial intelligence and machine learning, emphasis on sustainability and environmentally friendly products, partnerships between healthcare providers and technology companies, and elevated R&D investment from pharmaceutical companies.
What Are The Leading Drivers Of Growth In The Constipation Treatment Market?
The rise in fast food consumption is anticipated to fuel the expansion of the constipation treatment market. Fast food pertains to hot dishes that a patron cooks or orders from a certain type of eatery, delivered in a short amount of time. These convenient foods are generally low in fiber but high in fat and salt, contributing to constipation. For example, a report by Budget Branders, a US-based supplier of paper and plastic goods, cited in August 2023 that the fast-food industry is predicted to attain a global market value of 931.7 billion dollars by 2027. Not to mention, the US houses more than 200,000 different fast-food establishments, with American customers annually spending 200 billion dollars on such food. Thus, the surge in fast food intake is spearheading the development of the constipation treatment market.
How Are The Segments Defined Within The Global Constipation Treatment Market?
The constipation treatment market covered in this report is segmented –
1) By Therapeutic Types: Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, GC-C (Guanylate Cyclase-C) Agonists, Other Therapeutics
2) By Disease Type: Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome With Constipation (IBS-C), Opioid-Induced Constipation (OIC)
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Laxatives: Osmotic Laxatives, Stimulant Laxatives, Bulk-Forming Laxatives, Stool Softeners, Chloride Channel Activators
2) By Chloride Channel Activators: Lubiprostone, Other Chloride Channel Activators
3) By Peripherally Acting Mu-Opioid Receptor Antagonists: Methylnaltrexone, Naloxegol, Other Mu-Opioid Receptor Antagonists
4) By GC-C (Guanylate Cyclase-C) Agonists: Plecanatide, Linaclotide
5) By Other Therapeutics: Probiotics, Dietary Supplements, Other Emerging Therapies
Pre-Book The Constipation Treatment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Constipation Treatment Market?
The emergence of product innovation is a vital trend in the constipation treatment market that is gaining increased recognition. Business entities in this field are initiating new product innovations to maintain their market stance. Ardelyx, a biopharmaceutical organization based in the US, spearheaded this trend in April 2022 by introducing IBSRELA, a groundbreaking treatment for adults suffering from irritable bowel syndrome with constipation (IBS-C). IBSRELA stands as the initial innovative mechanism therapy for this condition to be launched in over a decade, offering an essential new alternative for dealing with constipation, bloating, and stomach pain symptomatic of this debilitating disorder.
Who Are the Key Players in the Constipation Treatment Market?
Major companies operating in the constipation treatment market include:
• Pfizer Inc.
• Johnson & Johnson
• AbbVie Inc.
• Bayer AG
• Novartis AG
• Merck & Co. Inc.
• Sanofi S.A.
• AstraZeneca plc
• Fresenius Kabi AG
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Ltd.
• Boehringer Ingelheim International GmbH
• Regeneron Pharmaceuticals
• Bausch Health Companies Inc.
• Eisai Co. Ltd.
• Shionogi & Co. Ltd.
• Mallinckrodt Plc
• Salix Pharmaceuticals Inc.
• Prestige Consumer Healthcare Inc.
• Taiho Pharmaceutical Co. Ltd.
• Ironwood Pharmaceuticals Inc.
• Cosmo Pharmaceuticals NV
• Ferring Pharmaceuticals
• RedHill Biopharma Ltd.
• Probi AB
• 4D Pharma plc
What Is The Most Dominant Region In The Constipation Treatment Market?
North America was the largest region in the constipation treatment market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the constipation treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
